<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">ETM</journal-id>
<journal-title-group>
<journal-title>Experimental and Therapeutic Medicine</journal-title>
</journal-title-group>
<issn pub-type="ppub">1792-0981</issn>
<issn pub-type="epub">1792-1015</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/etm.2017.4071</article-id>
<article-id pub-id-type="publisher-id">ETM-0-0-4071</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Impact of gabapentin on neuronal high voltage-activated Ca<sup>2&#x002B;</sup> channel properties of injured-side axotomized and adjacent uninjured dorsal root ganglions in a rat model of spinal nerve ligation</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Zhu</surname><given-names>Minmin</given-names></name>
<xref rid="af1-etm-0-0-4071" ref-type="aff">1</xref>
<xref rid="af2-etm-0-0-4071" ref-type="aff">2</xref>
<xref rid="fn1-etm-0-0-4071" ref-type="author-notes">&#x002A;</xref></contrib>
<contrib contrib-type="author"><name><surname>Sun</surname><given-names>Xiaodi</given-names></name>
<xref rid="af3-etm-0-0-4071" ref-type="aff">3</xref>
<xref rid="fn1-etm-0-0-4071" ref-type="author-notes">&#x002A;</xref></contrib>
<contrib contrib-type="author"><name><surname>Chen</surname><given-names>Xiaodong</given-names></name>
<xref rid="af3-etm-0-0-4071" ref-type="aff">3</xref></contrib>
<contrib contrib-type="author"><name><surname>Xiao</surname><given-names>Hang</given-names></name>
<xref rid="af4-etm-0-0-4071" ref-type="aff">4</xref></contrib>
<contrib contrib-type="author"><name><surname>Duan</surname><given-names>Manlin</given-names></name>
<xref rid="af1-etm-0-0-4071" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Xu</surname><given-names>Jianguo</given-names></name>
<xref rid="af1-etm-0-0-4071" ref-type="aff">1</xref>
<xref rid="c1-etm-0-0-4071" ref-type="corresp"/></contrib>
</contrib-group>
<aff id="af1-etm-0-0-4071"><label>1</label>Department of Anaesthesiology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu 210002, P.R. China</aff>
<aff id="af2-etm-0-0-4071"><label>2</label>Department of Anaesthesiology, Wuxi Second Hospital, Nanjing Medical University, Wuxi, Jiangsu 214002, P.R. China</aff>
<aff id="af3-etm-0-0-4071"><label>3</label>Department of Anaesthesiology, First Hospital, Nanjing Medical University, Nanjing, Jiangsu 210002, P.R. China</aff>
<aff id="af4-etm-0-0-4071"><label>4</label>Department of Toxicology, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China</aff>
<author-notes>
<corresp id="c1-etm-0-0-4071"><italic>Correspondence to</italic>: Dr Jianguo Xu, Department of Anaesthesiology, Jinling Hospital, School of Medicine, Nanjing University, 305 East Zhongshan Road, Nanjing, Jiangsu 210002, P.R. China, E-mail: <email>jianguoxucn@126.com</email></corresp>
<fn id="fn1-etm-0-0-4071"><label>&#x002A;</label><p>Contributed equally</p></fn>
</author-notes>
<pub-date pub-type="ppub">
<month>03</month>
<year>2017</year></pub-date>
<pub-date pub-type="epub">
<day>20</day>
<month>01</month>
<year>2017</year></pub-date>
<volume>13</volume>
<issue>3</issue>
<fpage>851</fpage>
<lpage>860</lpage>
<history>
<date date-type="received"><day>20</day><month>07</month><year>2015</year></date>
<date date-type="accepted"><day>27</day><month>09</month><year>2016</year></date>
</history>
<permissions>
<copyright-statement>Copyright: &#x00A9; Zhu et al.</copyright-statement>
<copyright-year>2017</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivs License</ext-link>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p></license>
</permissions>
<abstract>
<p>The density and properties of ion channels in the injured axon and dorsal root ganglion (DRG) neuronal soma membrane change following nerve injury, which may result in the development of neuropathic pain. Gabapentin (GBP) is a drug for the first-line treatment of neuropathic pain. One of its therapeutic targets is the voltage-activated calcium channel (VACC). In the present study, the whole-cell patch clamp technique was used to examine the changes of high voltage-activated Ca<sup>2&#x002B;</sup> (HVA-Ca<sup>2&#x002B;</sup>) channels in DRG neurons from sham and neuropathic rats in the absence and presence of GBP. The results demonstrated a reduction in peak current density and the &#x2018;window current&#x2019; between activation and inactivation in adjacent and axotomized neurons from rats that had undergone L<sub>5</sub> spinal nerve ligation, thus attenuating the total inward Ca<sup>2&#x002B;</sup> current. Following the use of the specific channel blockers nifedipine, &#x03C9;-conotoxin MVIIC and &#x03C9;-conotoxin MVIIA, increased HVA-Ca<sup>2&#x002B;</sup> channels as well as an increased proportion of N-type Ca<sup>2&#x002B;</sup> currents were observed in axotomized neurons. GBP inhibited HVA calcium channel currents in a dose-dependent manner. The activation and steady-state inactivation curves for HVA channels were shifted in a hyperpolarizing direction by 100 &#x00B5;mol/l GBP. Following the application of GBP, a reduction in the &#x2018;window current&#x2019; was observed in control and axotomized neurons, whereas the &#x2018;window current&#x2019; was unchanged in adjacent neurons. This indicates that the inhibitory effects of GBP may be dependent on particular neuropathological or inflammatory conditions. The proportion of N-type Ca<sup>2&#x002B;</sup> currents and sensitivity to GBP were increased in axotomized neurons, which indicated the involvement of N-type Ca<sup>2&#x002B;</sup> currents in the inhibitory effect of GBP.</p>
</abstract>
<kwd-group>
<kwd>spinal nerve ligation</kwd>
<kwd>dorsal root ganglion</kwd>
<kwd>high-voltage-activated Ca<sup>2&#x002B;</sup> channel</kwd>
<kwd>gabapentin</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Neuropathic pain results from lesions to the peripheral nervous system (PNS) caused by infection, mechanical trauma, neurotoxic chemicals, metabolic diseases or tumor invasion (<xref rid="b1-etm-0-0-4071" ref-type="bibr">1</xref>). It involves a number of pathophysiological changes that occur within the central and peripheral nervous systems (<xref rid="b1-etm-0-0-4071" ref-type="bibr">1</xref>). Afferent discharge may emanate from the injury site and neuronal somata in the dorsal root ganglion (DRG), or even elsewhere along the injured axons in response to certain physical or chemical stimuli. This may lead to peripheral and central sensitization, an important causative factor for the onset and maintenance of neuropathic symptoms, including spontaneous pain, hyperalgesia and allodynia (<xref rid="b1-etm-0-0-4071" ref-type="bibr">1</xref>,<xref rid="b2-etm-0-0-4071" ref-type="bibr">2</xref>). Following peripheral nerve injury, the ipsilateral injured side contains injured and intact sensory axons and neurons.</p>
<p>L<sub>5</sub> spinal nerve ligation (SNL) is an experimental neuropathic pain model exhibiting a clear separation between injured and non-injured cell bodies (<xref rid="b3-etm-0-0-4071" ref-type="bibr">3</xref>). It has been demonstrated that almost all L<sub>5</sub> DRG neurons were axotomized following transection of the L<sub>5</sub> spinal nerve, while the L<sub>4</sub> ganglionic cells infiltrated the degenerating L<sub>5</sub> axonal environments. The contribution of injured and intact sensory neurons to the onset and maintenance of neuropathic pain is controversial (<xref rid="b4-etm-0-0-4071" ref-type="bibr">4</xref>). Sapunar <italic>et al</italic> (<xref rid="b5-etm-0-0-4071" ref-type="bibr">5</xref>) observed that distinct electrophysiological changes occur in injured and adjacent DRG membranes. The afterhyperpolarization (AHP) duration in L<sub>5</sub> neurons with C fibers shortened following axotomy, while adjacent L<sub>4</sub> neurons showed no change in action potential duration, AHP dimensions or excitability following SNL. However, an <italic>in vivo</italic> study demonstrated that, following SNL, electrophysiological changes occurring in large- and medium-sized somata of intact (L<sub>4</sub>) as well as axotomized (L<sub>5</sub>) DRG neurons were similar and included a longer action potential (AP) duration, slower AP rise and falling rates, a lower current and voltage threshold, and a higher input resistance (<xref rid="b6-etm-0-0-4071" ref-type="bibr">6</xref>).</p>
<p>Following peripheral nerve lesion, the distribution and properties of transmembrane ion channels in injured axons and DRG neurons change, leading to alterations in the excitability and conductive properties of peripheral afferent fibers (<xref rid="b7-etm-0-0-4071" ref-type="bibr">7</xref>). DRG neurons express a variety of VACCs, a family of transmembrane proteins widely distributed in excitable cells and also detected in a number of non-excitable cells. When the plasma membrane becomes depolarized, the VACC channels open, mediating Ca<sup>2&#x002B;</sup> entry in response to sub-threshold depolarizing signals and APs (<xref rid="b8-etm-0-0-4071" ref-type="bibr">8</xref>). &#x03B1;2&#x03B4;1 is the most abundant VACC sub-type in the spinal cord and DRG, and co-expression of &#x03B1;2&#x03B4;1 with &#x03B1;1 and &#x03B2; VACC sub-units <italic>in vitro</italic> results in accelerated activation, inactivation kinetics and increased calcium current density (<xref rid="b9-etm-0-0-4071" ref-type="bibr">9</xref>). Increased &#x03B1;2&#x03B4;1 sub-unit expression and calcium channel activity in the dorsal horn have been observed in neuropathic pain (<xref rid="b10-etm-0-0-4071" ref-type="bibr">10</xref>). Furthermore, it has been demonstrated that gabapentin (GBP), the first-line drug for the treatment of neuropathic pain, specifically binds to the &#x03B1;2&#x03B4;1 sub-unit of N-type VDCCs and exerts various actions responsible for pain attenuation (<xref rid="b11-etm-0-0-4071" ref-type="bibr">11</xref>).</p>
<p>In the present study, nerve injury-induced changes in the electrophysiological properties of DRG high-voltage activated (HVA)-Ca<sup>2&#x002B;</sup> currents were examined, as well as the influence of GBP on these changes in injured-side axotomized and adjacent uninjured DRGs in model rats subjected to SNL.</p>
</sec>
<sec sec-type="materials|methods">
<title>Materials and methods</title>
<sec>
<title/>
<sec>
<title>Surgical procedure</title>
<p>A total of 96 healthy male Sprague-Dawley (SD) rats (age, 4&#x2013;6 weeks; weight, 120&#x2013;150 g) were purchased from the Model Animal Research Center of Nanjing University (Nanjing, China). They were kept under a temperature of 22&#x2013;24&#x00B0;C, a humidity of 50&#x2013;60&#x0025; and a 12 h light-dark cycle. All rats had <italic>ad libitum</italic> access to food and water. Rats were randomly divided into two groups: An SNL group (n=60) and a sham group (n=36). The 60 rats in the SNL group received a unilateral, tight ligation and transection of the left L<sub>5</sub> spinal nerve using a modification of the surgical procedure previously described by Kim and Chung (<xref rid="b12-etm-0-0-4071" ref-type="bibr">12</xref>). In brief, under anesthesia with 2&#x0025; pentobarbital sodium administered intraperitoneally (i.p., 50 mg/kg; Sigma-Aldrich; Merck Millipore, Darmstadt, Germany) and following exposure of the left L<sub>5</sub> spinal nerve, the left L<sub>5</sub> and L<sub>4</sub> spinal nerves were identified. The left L<sub>5</sub> spinal nerve was separated and tightly ligated with 5&#x2013;0 silk sutures between the DRG and the conjunction to form the sciatic nerve and transected just distal to the ligature. The 36 sham rats underwent exposure, while they did not undergo ligation or transection of the spinal nerve. The present study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The experimental animal protocol was reviewed and approved by the Institutional Animal Care and Use Committee of Nanjing University (Nanjing, China).</p>
</sec>
<sec>
<title>Behavioral tests</title>
<p>All experimental rats were subjected to behavioral tests at 1 day prior to as well as 1, 3, 7 and 14 days following surgery. All tests were repeated three times.</p>
<p>To assess tactile allodynia, rats in clear plastic cages with a wire mesh bottom were tested using an up-down method as described by Choi <italic>et al</italic> (<xref rid="b13-etm-0-0-4071" ref-type="bibr">13</xref>). A filament (Supertips&#x2122; flexible Von Frey hairs, IITC Life Science, Woodland Hills, CA, USA) with a suitable, calibrated buckling weight was applied to the plantar surface of the hind paw with pressure causing the filament to bend. Absence of paw lifting after 4 sec led to the use of the next filament with increased weight, whereas paw lifting indicated a positive response and led to the use of the next weaker filament. This paradigm continued until the withdrawal threshold was estimated as the smallest fiber size that evoked at least three withdrawal responses during five consecutive applications with the same fiber.</p>
<p>A von Frey mechanical pain threshold detector (Model 2390 Electric von Frey aesthesiometer; IITC Life Science) was used to assess mechanical hyperalgesia. A paw-flick response was elicited by applying increasing force (in g) using rigid tips (400 g; Model 2391; IITC Life Science) focused on the plantar surface of the hindpaw. The force applied that elicited a reflex removal of the hindpaw was recorded.</p>
<p>Thermal hyperalgesia was determined by comparison of paw withdrawal latency to thermal stimuli between operated and non-operated sides. Rats were exposed to a radiant source generated and controlled by an IITC Model 390 Analgesia Meter (10 V; 30 W; spot dimensions, 4&#x00D7;6 mm; IITC Life Science). The light radiation intensity was set at 50&#x0025; with intervals of 30 sec (in order to avoid extensive damage).</p>
</sec>
<sec>
<title>Dissociation of DRG neurons</title>
<p>At 15 days after surgery, rats in the SNL or sham group were anesthetized with 2&#x0025; pentobarbital sodium (50 mg/kg i.p., Sigma-Aldrich; Merck Millipore) for the dissociation of DRG neurons. The L<sub>4</sub> and L<sub>5</sub> DRGs and attached dorsal roots were removed and the connective tissue capsule was dissected using microdissection scissors in ice-cold, oxygenated, buffered Dulbecco&#x0027;s modified Eagle&#x0027;s medium (DMEM, High Glucose, Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) containing 3.7 g/l NaHCO<sub>3</sub> (pH 7.2). DRG fragments were rinsed with DMEM three times and subsequently transferred into 1.5 ml DMEM containing 2 mg/ml type I collagenase (Sigma-Aldrich; Merck Millipore) and 1.2 mg/ml type I trypsin (Sigma-Aldrich; Merck Millipore) and aerated with 5&#x0025; CO<sub>2</sub> and 95&#x0025; O<sub>2</sub> at 36.5&#x00B0;C for 25 min until complete dissociation was confirmed microscopically. DRG neurons were rinsed in an oxygenated, standard extracellular solution containing 145 mmol/l tetraethylammonium chloride, 0.8 mmol/l MgCl<sub>2</sub>, 5 mmol/l CaCl<sub>2</sub>, 20 mmol/l 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES; Sigma-Aldrich, Merck Millipore) and 10 mmol/l D-glucose (the pH was adjusted to 7.3 with Tris base) to terminate the enzyme reactions. Individual neurons were dissociated by passing DRG fragments through a set of fire-polished glass pipettes. Finally, neurons were plated onto culture dishes consisting of extracellular solution through the coated metallic screen (250 mesh, WS Tyler, Mentor, OH, USA). Cells were allowed to attach to the culture dishes for 2&#x2013;3 h at room temperature.</p>
</sec>
<sec>
<title>Whole-cell patch-clamp recording</title>
<p>Neurons were studied 8&#x2013;10 h after dissociation. Cells were visualized with an inverted microscope and their soma diameter was determined as small (&#x003C;30 &#x00B5;m), medium (30&#x2013;40 &#x00B5;m) or large (&#x003E;40 &#x00B5;m) with the aid of a calibrated microscope eyepiece reticle (Olympus Corporation, Tokyo, Japan). The subsequent analysis focused on the medium-diameter neurons, which were considered as the nociceptive afferent (A&#x03B4; and C fibres, slow-conducting velocities) and low-threshold sensory afferent (<xref rid="b14-etm-0-0-4071" ref-type="bibr">14</xref>).</p>
<p>Whole-cell configuration of the patch-clamp technique was used for current clamp and voltage-clamp electrophysiological recordings using the EPC-9 patch-clamp amplifier (HEKA Elektronik, Lambrecht, Germany) with an AgCl reference electrode. Electrical stimuli pulses and current recording were controlled and performed using PULSE&#x002B;PULSEFIT ver. 8.79 (HEKA Elektronik). Channel currents were sampled using the ITC-16 data acquisition system (InstruTech; HEKA Elektronik). Recordings were acquired at 20 kHz, filtered at 2 kHz and sampled using a computer with Digidata 1200 A/D acquisition board (HEKA Elektronik) for offline analyses. Sigmaplot ver. 10.0 (Systat software, Inc., San Jose, CA, USA) was used for data analysis. The current-voltage curves were generated using Igor pro 4.0 (WaveMetrics, Inc., Lake Oswego, OR, USA) software.</p>
<p>Micro-electrodes were pulled from glass capillaries (diameter, 1.6 mm; Beijing Xianqu Weifeng Technology Development Co., Beijing, China) using a pipette puller (PP-830; Narishige Scientific Instrument Lab., Tokyo, Japan). The diameter of the micro-electrode tip was 1&#x2013;2 mm. The resistance of the internal solution [CsCl 135 mmol/l, MgCl<sub>2</sub> 2 mmol/l, EGTA 11 mmol/l, CaCl<sub>2</sub> 1 mmol/l, HEPES 20 mmol/l, magnesium-adenosine triphosphate (Mg-ATP) 5 mmol/l, guanosine 5&#x2032;-triphosphate lithium salt (Li-GTP) 0.4 mmol/l, pH 7.3], filled into pipettes was 3&#x2013;6 M&#x03A9;. Micropipettes were positioned on the membrane and gentle suction was applied to obtain a resistant seal in the G&#x03A9; range (&#x003E;1 G&#x03A9;). Following rupture of the membrane with suction at negative pressure, entering the whole-cell recording configuration, neurons were allowed to reach adequate equilibration between the internal pipette solution and the cell interior for 10 min. The slow capacitance, system resistance, series resistance, capacitance current and leakage current were electronically compensated with the compensation circuitry of the amplifier during current recording. Effective data was defined as a steady current and series resistance &#x003C;20 M&#x03A9;.</p>
</sec>
<sec>
<title>Drug application</title>
<p>Drugs were added to extracellular solution, bathing the dissociated DRG neurons. Fluid changes and continuous perfusions were achieved through a gravity-dependent flow system. Stocks of GBP, &#x03C9;-conotoxin MVIIC, &#x03C9;-conotoxin MVIIA, CdCl<sub>2</sub> and Li-GTP (Sigma-Aldrich; Merck Millipore) were prepared in distilled water and stored at &#x2212;20&#x00B0;C.</p>
</sec>
<sec>
<title>Data analysis and statistics</title>
<p>The current density of certain cells was obtained from the inward current standardized by the membrane capacitance and compared with those of other cells. The voltage-dependent current curve was fit according to the Boltzmann equation, G/G<sub>max</sub>=1/{1&#x002B;exp[(Va<sub>1/2</sub>-Vm)/Ka]}, where G is the conductance calculated as G=I/(V<sub>m</sub>-V<sub>r</sub>), where I is the current, V<sub>m</sub> is the command voltage, V<sub>r</sub> is the reversal potential, Va<sub>1/2</sub> is the voltage at the half maximal activation current and Ka is the slope factor describing the voltage dependence of the conductance. The curve of the steady-state inactivation current was fit according to the Boltzmann equation, I/I<sub>max</sub> = 1 / {1 &#x002B; exp [(V - Vi<sub>1/2</sub>) / Ki]}, where I is the current, V is the pre-stimulus voltage, Vi<sub>1/2</sub> is the voltage at the half maximal inactivation current and <italic>K</italic>i is the slope factor of inactivation.</p>
<p>SPSS statistical software ver. 16.0 (SPSS Inc., Chicago, IL, USA) was used for statistical analysis. Values are expressed as the mean &#x00B1; standard deviation. Two-way analysis of variance was used for comparison among groups and the q test was used for pairwise comparison. Statistical analysis between any two groups was performed using the group <italic>t</italic>-test and a paired <italic>t</italic>-test was used for comparison of pre- and post-drug application within groups. P&#x003C;0.05 was considered to indicate a statistically significant difference.</p>
</sec>
</sec>
</sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title/>
<sec>
<title>Confirmation of establishment of the rat model of neuropathic pain</title>
<p>All SNL-treated rats that underwent electrophysiological analysis exhibited clear behavioral indications of allodynia, mechanical hyperalgesia and thermal hyperalgesia. Prior to surgery, no significant differences in the mean foot withdrawal threshold were observed between the contralateral and ipsilateral feet of the mice in each group as well as between the SNL and sham groups. Mean withdrawal thresholds obtained from the feet ipsilateral to the SNL decreased significantly on the first post-operative day and remained significantly lower than the pre-operative value for up to 14 post-operative days (P&#x003C;0.05; <xref rid="f1-etm-0-0-4071" ref-type="fig">Fig. 1A and B</xref>). By contrast, there were no significant changes in the withdrawal threshold in paws contralateral to the SNL between the groups or for either foot in the sham-operated group. The latency for foot withdrawal in SNL rats significantly decreased in response to thermal stimuli delivered to the ipsilateral foot on the first post-operative day and remained lower during the entire observation period, compared with the non-operated side in the SNL rats (P&#x003C;0.05; <xref rid="f1-etm-0-0-4071" ref-type="fig">Fig. 1C</xref>). However, latency was not affected by the sham operation.</p>
</sec>
<sec>
<title>Dose-dependent inhibition of the HVA-Ca<sup>2&#x002B;</sup> peak current by GBP</title>
<p>After entering the whole-cell recording configuration, inward currents were activated under the command voltage from &#x2212;70 to &#x002B;40 mV at 80-msec intervals in 10 mV increments and with a holding potential (V<sub>H</sub>) of &#x2212;90 mV. There were no low-voltage-activated (LVA) components and no fast component of inactivation in the inward currents. Activation of inward currents occurred at &#x2212;40 mV and peak inward currents occurred at 0 mV according to the current density-potential (I&#x2013;V) curve. Inward currents were completely suppressed following the addition of 200 &#x00B5;mol/l CdCl<sub>2</sub> with the same stimuli, which was in accordance with the properties of HVA-Ca<sup>2&#x002B;</sup> currents (<xref rid="f2-etm-0-0-4071" ref-type="fig">Fig. 2</xref>).</p>
<p>Voltage steps of 80 msec were applied to various test potentials between &#x2212;70 and &#x002B;40 mV in 10-mV steps with 5-sec intervals from a V<sub>H</sub> of &#x2212;90 mV. This was performed to examine current-voltage associations in axotomized, adjacent neurons and control neurons from the L<sub>4</sub> and L<sub>5</sub> DRGs and attached dorsal roots of sham-operated rats. Peak inward calcium current levels were measured, corrected for cell size and subsequently expressed as the peak current density (pA/pF). Peak current densities of control, adjacent and axotomized neurons were 144&#x00B1;24, 104&#x00B1;17 and 75&#x00B1;17 pA/pF, respectively. Compared with that of control neurons, the peak current density of adjacent and axotomized neurons decreased significantly (P&#x003C;0.05) and the peak current density of axotomized neurons was significantly lower than that of adjacent neurons (P&#x003C;0.05). The activation voltage of the peak HVA-Ca<sup>2&#x002B;</sup> current density in control and adjacent neurons was 0 mV, while that of axotomized neurons was &#x2212;10 mV (<xref rid="f3-etm-0-0-4071" ref-type="fig">Fig. 3</xref>).</p>
<p>Steady maximal activation of HVA-Ca<sup>2&#x002B;</sup> currents was achieved with a voltage of V= 10 or 0 mV at 80-msec intervals and the dose-dependent inhibition effect of GBP was subsequently determined using 0.1, 1, 10, 100 and 300 &#x00B5;mol/l GBP. Changes in peak inward Ca<sup>2&#x002B;</sup> flux (ICa) were recorded and the inhibition of currents with GBP at various doses was calculated. The peak ICa was significantly enhanced in cells exposed to higher concentrations of GBP (10, 100 and 300 &#x00B5;mol/l; P&#x003C;0.05), in comparison with cells exposed to lower concentrations of GBP (0.1 and 1 &#x00B5;mol/l). GBP significantly inhibited the peak inward ICa in a dose-dependent manner. Furthermore, the inhibitory effects of GBP on the peak current of axotomized neurons at concentrations of 10, 100 and 300 &#x00B5;mol/l were significantly higher than those on the current of control and adjacent neurons (P&#x003C;0.05). There were no significant differences in the inhibitory effects on the peak current between control and adjacent neurons at various concentrations of GBP (P&#x003E;0.05; <xref rid="tI-etm-0-0-4071" ref-type="table">Table I</xref>).</p>
</sec>
<sec>
<title>Effects of GBP on the kinetics of HVA-Ca<sup>2&#x002B;</sup> channels</title>
<p>The membrane V<sub>H</sub> was set at &#x2212;90 mV and calcium currents were elicited by a series of command voltages (range, &#x2212;70 to &#x002B;40 mV) with successive increments of 10 mV at 80-msec intervals. As shown in <xref rid="f4-etm-0-0-4071" ref-type="fig">Fig. 4</xref>, the midpoint potentials for the activation curves (Va<sub>1/2</sub>) of control, adjacent and axotomized neurons were &#x2212;16.23&#x00B1;1.92, &#x2212;18.03&#x00B1;0.37 and &#x2212;20.73&#x00B1;0.33 mV, respectively, with the Va<sub>1/2</sub> of axotomized neurons being significantly lower than that of the control and adjacent neurons (P&#x003C;0.05; <xref rid="f4-etm-0-0-4071" ref-type="fig">Fig. 4C</xref>); however, no difference was observed between those of the control and adjacent neurons (P&#x003E;0.05; <xref rid="f4-etm-0-0-4071" ref-type="fig">Fig. 4C</xref>). To study the kinetics of channel inactivation, calcium currents were generated by applying a membrane V<sub>H</sub> at &#x2212;90 mV for 10 msec, followed by series of command voltages from &#x2212;70 to &#x002B;20 mV with successive increments of 10 mV at 500-msec intervals. Subsequently, command voltages of &#x2212;10 mV at 80-msec intervals were applied. The midpoint potentials for the inactivation curves (Vi<sub>1/2</sub>) of control, adjacent and axotomized neurons were &#x2212;31.93&#x00B1;1.03, &#x2212;31.45&#x00B1;1.87 and &#x2212;32.73&#x00B1;1.37 mV, respectively. There were no significant differences in the midpoint potentials among the three types of neurons (P&#x003E;0.05; <xref rid="f4-etm-0-0-4071" ref-type="fig">Fig. 4D</xref>).</p>
<p>To study the effects of GBP on the kinetics of HVA-Ca<sup>2&#x002B;</sup> channel activation, I&#x2013;V associations for the transient calcium channel currents were plotted using 10-mV incremental step pulses from &#x2212;70 to &#x002B;40 mV at 80-msec intervals with a membrane V<sub>H</sub> at &#x2212;90 mV in the presence of 100 &#x00B5;mol/l GBP. The Va<sub>1/2</sub> decreased from &#x2212;16.23&#x00B1;1.92 to &#x2212;19.69&#x00B1;1.07 mV (P&#x003C;0.05), &#x2212;18.03&#x00B1;0.37 to &#x2212;21.73&#x00B1;0.64 mV (P&#x003C;0.05) and &#x2212;20.73&#x00B1;0.33 to &#x2212;23.94&#x00B1;0.15 mV (P&#x003C;0.05) in the control, adjacent and axotomized neurons, respectively (<xref rid="f5-etm-0-0-4071" ref-type="fig">Fig. 5</xref>). To investigate the effects of GBP on the kinetics of HVA-Ca<sup>2&#x002B;</sup> channel inactivation, steady-state inactivation was measured in a conventional way using a 500-msec pre-pulse from &#x2212;70 to &#x002B;20 mV in 10-mV increments with a &#x2212;90-mV membrane V<sub>H</sub> for 10 msec followed by a second test pulse at &#x2212;10 mV for 80 msec in the presence of 100 &#x00B5;mol/l GBP. By addition of 100 &#x00B5;mol/l GBP, the current required to inactivate Va1/2 was decreased from &#x2212;38.78&#x00B1;2.05 to &#x2212;31.93&#x00B1;1.03 mV in control neurons, from &#x2212;36.22&#x00B1;2.80 to &#x2212;31.45&#x00B1;1.87) mV in adjacent neurons and from &#x2212;44.23&#x00B1;2.30 to &#x2212;32.73&#x00B1;1.37 mV in axotomized neurons (<xref rid="f5-etm-0-0-4071" ref-type="fig">Fig. 5</xref>).</p>
<p>The voltage dependence of activation shifted in a depolarized direction, whereas the Vi<sub>1/2</sub> remained unchanged in axotomized as well as adjacent uninjured DRG neurons, compared with those in control neurons. The shift in activation reduced the &#x2018;window current&#x2019; between inactivation and activation, thereby stopping the sustained inward ICa. Following the addition of GBP, the activation and steady-state Vi<sub>1/2</sub> of three groups all shifted in a hyperpolarized direction. The shift in activation and inactivation reduced the overlap (&#x2018;window currents&#x2019;) between inactivation and activation in control and axotomized neurons, while the &#x2018;window currents&#x2019; remained unchanged in adjacent neurons (<xref rid="f5-etm-0-0-4071" ref-type="fig">Fig. 5</xref>).</p>
</sec>
<sec>
<title>Effects of SNL injury and GBP on HVA-Ca<sup>2&#x002B;</sup> channel currents</title>
<p>Maximal activation of the HVA-Ca<sup>2&#x002B;</sup> currents occurred with V=10 or 0 mV at 80-msec intervals, with a membrane V<sub>H</sub> of &#x2212;90 mV. To individually assess different sub-types of HVA-Ca<sup>2&#x002B;</sup> channels present in the same cell, 20 &#x00B5;mol/l nifedipine (L-type calcium channel blocker), 2 &#x00B5;mol/l &#x03C9;-conotoxin MVIIC (P/Q-type calcium channel blocker) and 2 &#x00B5;mol/l &#x03C9;-conotoxin MVIIA (N-type calcium channel blocker) were applied to the bath in sequence when stable currents were reached. Similar activation voltages were applied to the same cells to evoke Ca<sup>2&#x002B;</sup> currents. Currents subtracted prior to and following application of respective blocker yielded L-, N-, P/Q-type currents. Subsequently, 100 &#x00B5;mol/l GBP was applied to determine its inhibitory efficacy on various sub-types of HVA calcium channel current.</p>
<p>As shown in <xref rid="f6-etm-0-0-4071" ref-type="fig">Fig. 6</xref>, the proportion of N-type Ca<sup>2&#x002B;</sup> currents in axotomized neurons was significantly higher (50.0&#x00B1;2.7&#x0025;) than that in control neurons (35.9&#x00B1;1.4&#x0025;) and adjacent neurons (37.1&#x00B1;2.0&#x0025;; P&#x003C;0.05; <xref rid="f6-etm-0-0-4071" ref-type="fig">Fig. 6B</xref>). The contribution of L-type channels to the HVA-Ca<sup>2&#x002B;</sup> influx in axotomized neurons was markedly reduced, as 15.4&#x00B1;2.3&#x0025; of the HVA-Ca<sup>2&#x002B;</sup> current was blocked by 20 &#x00B5;mol/l nifedipine compared to 27.9&#x00B1;2.5&#x0025; in control neurons and 26.1&#x00B1;1.8&#x0025; in adjacent neurons (P&#x003C;0.05). There was no significant difference in the proportion of each sub-type of HVA-Ca<sup>2&#x002B;</sup> channel current between adjacent and control neurons (P&#x003E;0.05; <xref rid="f6-etm-0-0-4071" ref-type="fig">Fig. 6B</xref>). However, the P/Q-type current was similar between the three groups.</p>
<p>The proportion of N-type Ca<sup>2&#x002B;</sup> currents in axotomized neurons was significantly higher (81.0&#x00B1;2.8&#x0025;) than that in control and adjacent neurons (68.8&#x00B1;4.5 and 69.7&#x00B1;3.3&#x0025;, respectively; P&#x003C;0.05), suggesting that the N-type Ca<sup>2&#x002B;</sup> channel current is the GBP-sensitive sub-type of HVA-Ca<sup>2&#x002B;</sup> channel currents (<xref rid="tII-etm-0-0-4071" ref-type="table">Table II</xref>). However, the N- and P/Q-type currents were not affected by GBP.</p>
</sec>
</sec>
</sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>The present study demonstrated that SNL of the peripheral nerve of rats as a model of neuropathic pain injury significantly reduced HVA-Ca<sup>2&#x002B;</sup> currents. A decrease in current density, changes in the proportion of HVA-Ca<sup>2&#x002B;</sup> channel current sub-types and a depolarizing shift in the voltage dependence of activation appeared to cause this reduction in HVA-Ca<sup>2&#x002B;</sup> currents.</p>
<p>According to the I&#x2013;V curves, the peak current density of axotomized neurons decreased and was lower than that of control and adjacent uninjured DRG neurons. Similar results have been observed in other rat models, including that of chronic constriction injury (CCI). In this model, the somata of acutely dissociated DRG neurons from hyperalgesic rats exhibited a decreased ICa and injury of medium and large neurons decreased the peak calcium channel current density (<xref rid="b15-etm-0-0-4071" ref-type="bibr">15</xref>). McCallum <italic>et al</italic> (<xref rid="b15-etm-0-0-4071" ref-type="bibr">15</xref>) examined the ICa specifically in axotomized neurons generated by SNL and indicated that current loss is present in all neuronal size groups. Furthermore, current loss was evident in the adjacent L<sub>4</sub> neurons. These results indicated that various types of nerve injury, such as axotomy, result in ICa loss in primary sensory neurons of all sizes and includes HVA and LVA current types. This may be a common feature of nerve injury (<xref rid="b16-etm-0-0-4071" ref-type="bibr">16</xref>).</p>
<p>One possible explanation for the reduction in Ca<sup>2&#x002B;</sup> currents in DRG neurons observed in the present study is that the calcium channel density in the membrane decreases following axotomy. This may occur due to alterations in channel synthesis or degradation, post-translational modifications affecting the insertion of the channel into the membrane or the transport rate of channels to more distal locations. Alternatively, changes in the single-channel properties of somatic calcium channels may occur (<xref rid="b17-etm-0-0-4071" ref-type="bibr">17</xref>). The present study compared changes in the HVA-Ca<sup>2&#x002B;</sup> channel kinetics in control, adjacent and axotomized DRG neurons in model rats subjected to SNL. It was demonstrated that neuropathic injury shifted the voltage dependence of activation in a depolarized direction, whereas Vi<sub>1/2</sub> remained unchanged in axotomized and adjacent uninjured DRG neurons. This shift in activation reduced the &#x2018;window current&#x2019; between inactivation and activation, thereby attenuating the sustained inward ICa. A similar decrease in the overlap of the Ca<sup>2&#x002B;</sup> influx has previously been observed in a rat model of CCI (<xref rid="b18-etm-0-0-4071" ref-type="bibr">18</xref>).</p>
<p>The importance of ICa in the functioning of neurons means that altered ICa may contribute to functional abnormalities that accompany neuropathic pain (<xref rid="b16-etm-0-0-4071" ref-type="bibr">16</xref>). It is possible that the elevated excitability observed in neurons following axonal injury is the result of diminished ICa. It has been demonstrated that the tetradotoxin-resistant (TTX-R) sodium current provides the greatest amount of total inward current during the downstroke and HVA calcium channels carry a substantial inward current in the form of an AP (<xref rid="b19-etm-0-0-4071" ref-type="bibr">19</xref>). These currents decreased in the TTX-R sodium channel and HVA calcium channels following axonal injury. The direct effect of ICa contributes to AP formation and admits Ca<sup>2&#x002B;</sup> through voltage-dependent calcium channels (VGCCs), which acts on Ca<sup>2&#x002B;</sup>-sensitive K<sup>&#x002B;</sup> channels thus generating inward Ca<sup>2&#x002B;</sup> flux through Ca<sup>2&#x002B;</sup>-sensitive K<sup>&#x002B;</sup> channels [IK(Ca)]. In surgery, they contribute to the repolarization of the AP and the generation of AHP (<xref rid="b16-etm-0-0-4071" ref-type="bibr">16</xref>). AHP determines spike frequency adaptation and the ability of sensory neurons to maintain rapidly firing pulse trains, thus regulating a critical aspect of neuronal excitability (<xref rid="b20-etm-0-0-4071" ref-type="bibr">20</xref>). There is a correlation between reduced inward ICa and delayed AP depolarization, whereas the outward current, presumably IK(Ca), is reduced at the onset of AHP and during the repolarization phase of the AP (<xref rid="b16-etm-0-0-4071" ref-type="bibr">16</xref>). Increased burst firing from decreased AHP results in greater nociceptive traffic on the secondary neurons of the dorsal horn, where prolonged AP duration results in greater excitatory neurotransmitter release (<xref rid="b16-etm-0-0-4071" ref-type="bibr">16</xref>). Increased repetitive firing during sustained depolarization occurs in traumatized nociceptive neurons following axotomy. Thus, axotomized neurons, particularly pain-conducting ones, become unstable and exhibit increased excitability (<xref rid="b16-etm-0-0-4071" ref-type="bibr">16</xref>).</p>
<p>In the present study, the reduction of peak current density and &#x2018;window currents&#x2019; was observed in adjacent neurons, similar to that in axotomized neurons, due to the injury-induced change of channel activation. L<sub>4</sub> afferent fibers commingled with degenerating L<sub>5</sub> axons in the peripheral nerve, therefore, Wallerian degeneration may result in enhanced excitability of intact neurons with somata in L<sub>4</sub> DRGs adjacent to the axotomized L<sub>5</sub> DRGs. For example, glial cell line-derived neurotrophic factor or nerve growth factor; cytokines, including tumor necrosis factor, interleukin-1 or other inflammatory mediators released by immune cells; and Schwann cells activated by L<sub>5</sub> axonal degeneration, may activate adjacent neurons and lead to hyperexcitability in adjacent neurons, which may result in changes occurring in the distribution and activation state of ion channels (<xref rid="b6-etm-0-0-4071" ref-type="bibr">6</xref>). Furthermore, intense bursts of activity along the L<sub>5</sub> pathway sensitize the spinal dorsal horn to input along intact (i.e. SNL L<sub>4</sub>) pathways, so that natural stimuli are perceived as more intense (<xref rid="b16-etm-0-0-4071" ref-type="bibr">16</xref>). The process of cross-excitation spreads activity among adjacent neurons in the DRG. The injured adjacent afferents remaining intact following SNL serve a critical role in the development of neuropathic pain by interacting with degenerating afferents and by peripherally-propagating injury discharge, thus inducing peripheral sensitization (<xref rid="b21-etm-0-0-4071" ref-type="bibr">21</xref>).</p>
<p>The present study revealed that in injured neurons, the proportion of L-type calcium currents decreased and N-type calcium currents increased, whereas the proportion of P/Q-type calcium currents remained unchanged compared with currents in control and adjacent uninjured neurons. Yang <italic>et al</italic> (<xref rid="b22-etm-0-0-4071" ref-type="bibr">22</xref>) and Sun <italic>et al</italic> (<xref rid="b23-etm-0-0-4071" ref-type="bibr">23</xref>) observed an upregulation of the N-type Ca<sup>2&#x002B;</sup> current in injured DRG neurons in partial sciatic nerve ligation and SNL models, respectively. Hogan <italic>et al</italic> (<xref rid="b24-etm-0-0-4071" ref-type="bibr">24</xref>) indicated that injury affected the HVA-Ca<sup>2&#x002B;</sup> currents of the N- and P/Q-type channels, whereas no effects on the L-type channel current were noted. Another study demonstrated that L-type calcium channel-associated gene expression decreased in rat DRGs following CCI and sciatic nerve axotomy (<xref rid="b25-etm-0-0-4071" ref-type="bibr">25</xref>). The proportion of N-type calcium currents in adjacent uninjured neurons remained unchanged, which may be due to the inflammatory environment caused by peripheral nerve injury. It has been determined that N-type calcium channel function changes in the rat dorsal horn during inflammation (<xref rid="b26-etm-0-0-4071" ref-type="bibr">26</xref>). Selective downregulation in the contribution of this calcium channel to excitatory synaptic transmission recorded from neurokinin 1 receptor-positive neurons was observed in the laminae I (<xref rid="b26-etm-0-0-4071" ref-type="bibr">26</xref>).</p>
<p>Results from animal experiments (<xref rid="b27-etm-0-0-4071" ref-type="bibr">27</xref>,<xref rid="b28-etm-0-0-4071" ref-type="bibr">28</xref>) and clinical applications (<xref rid="b29-etm-0-0-4071" ref-type="bibr">29</xref>) suggest that GBP exhibits significant efficacy in treating chronic pains, particularly neuropathological pain; however, distinct neuroplasticities in various neuropathies may underlie the complexity of the antiallodynic actions of GBP. This indicates that the different effects in treating neuropathological pain may be due to the specific mechanism of nerve injury. The results of the present study demonstrated the dose-dependent inhibition of GBP towards the HVA-Ca<sup>2&#x002B;</sup> currents of control, adjacent and axotomized DRG neurons. Following application of 10, 100 and 300 &#x00B5;mol/l GBP, peak current densities decreased in control, adjacent and axotomized neurons, among which the inhibitory effects on the neuronal HVA-Ca<sup>2&#x002B;</sup> current of axotomized DRG neurons were more significant. Sarantopoulos <italic>et al</italic> (<xref rid="b30-etm-0-0-4071" ref-type="bibr">30</xref>) demonstrated that GBP rapidly and reversibly decreased the neuronal peak ICa of sham and neuropathic rats in a concentration-dependent manner; however, with a lack of significant differences in decreases among various groups.</p>
<p>The Va<sub>1/2</sub> and Vi<sub>1/2</sub>, which were fitted using the Boltzmann equation, indicated a shift towards the hyperpolarized direction, and the &#x2018;window current&#x2019; between the activation curve and the homeostatic inactivation curve changed. An <italic>in vivo</italic> experiment performed by Sutton <italic>et al</italic> (<xref rid="b31-etm-0-0-4071" ref-type="bibr">31</xref>) revealed that the inhibitory effect of GBP was dose- and voltage-dependent, producing a hyperpolarizing shift in current-voltage curves and reducing the non-inactivating component of the whole-cell current activated at relatively depolarized potentials.</p>
<p>Spinal nerve injury may increase the expression of the VGCC alpha-2-delta-1 sub-unit in the spinal dorsal horn and sensory neurons in the DRG that correlate with established neuropathic pain states (<xref rid="b8-etm-0-0-4071" ref-type="bibr">8</xref>,<xref rid="b32-etm-0-0-4071" ref-type="bibr">32</xref>) and GBP-sensitive allodynia (<xref rid="b27-etm-0-0-4071" ref-type="bibr">27</xref>). The auxiliary &#x03B1;2&#x03B4; sub-unit is a membrane-anchored protein and interacts with the extracellular domains of the &#x03B1;1 sub-unit. Each auxiliary sub-unit is involved in the trafficking of the channel complex to the membrane and modifies current properties, including the kinetics of activation and inactivation. &#x03B1;2&#x03B4; sub-units modify inward calcium currents by regulating the &#x03B1;1 sub-unit (<xref rid="b33-etm-0-0-4071" ref-type="bibr">33</xref>). In addition, co-expression of &#x03B1;2&#x03B4; with various &#x03B1; and &#x03B2; sub-units results in the acceleration of current activation and inactivation, an increase in current density and dihydropyridine binding sites, and a hyperpolarising shift of the current-voltage curves (<xref rid="b9-etm-0-0-4071" ref-type="bibr">9</xref>). The a2&#x03B4;-1 sub-unit represents the target for gabapentin in the alleviation of hyperalgesia in experimental models of neuropathic pain (<xref rid="b34-etm-0-0-4071" ref-type="bibr">34</xref>).</p>
<p>The findings of the present study revealed that the mechanism of GBP blockage of HVA calcium channel currents correlates with the injury-induced changes of activation and inactivation kinetics of the HVA-Ca<sup>2&#x002B;</sup> channel.</p>
<p>In the SNL model, alterations of neural signaling in injured and uninjured neurons contributed to the development of neuropathic pain following peripheral nerve injury. However, the pathological mechanisms of the two types of neuronal damage with injured or uninjured neurons differ; the former may mainly be affected by the direct damage of SNL, while the latter primarily arises due to the reaction products associated with Wallerian degeneration following the SNL (<xref rid="b35-etm-0-0-4071" ref-type="bibr">35</xref>). In the present study, it was observed that the &#x2018;window current&#x2019; decreased in control and axotomized neurons, whereas the &#x2018;window current&#x2019; in adjacent neurons was unchanged following the application of GBP, indicating that its inhibitory effects may depend on the particular neuropathological or inflammatory conditions.</p>
<p>Furthermore, in the present study, there was a certain degree of overlap in the inhibitory effects of various Ca<sup>2&#x002B;</sup> channel blockers on the action of GBP. The mixed pharmacology of the GBP-sensitive current suggests that inhibition may reflect the direct action of GBP on a number of different sub-types of calcium channel, dominated by the N-type current in this cell-type, similar to results from the study by Sutton <italic>et al</italic> (<xref rid="b31-etm-0-0-4071" ref-type="bibr">31</xref>).</p>
<p>Among all VACCs, N-type Ca<sup>2&#x002B;</sup> channels, which are potential molecular targets, are considered to be the most important ones in mediating neuropathic pain and the GBP-dependent modulation of pre-synaptic N-type channels in DRG neurons may prove an important means of mediating neuronal excitability and neurotransmitter release (<xref rid="b31-etm-0-0-4071" ref-type="bibr">31</xref>). In the present study, the proportion of N-type Ca<sup>2&#x002B;</sup> currents among the GBP-sensitive Ca<sup>2&#x002B;</sup> currents was increased in axotomized neurons, resulting in an increase of the main action target channels of GBP, which may be one of the causes of its enhanced inhibitory effect on HVA-Ca<sup>2&#x002B;</sup> currents in injured DRG neurons.</p>
<p>In conclusion, the present study demonstrated that the inhibitory effect of GBP on HVA-Ca<sup>2&#x002B;</sup> currents was enhanced in the injured DRG neurons of neuropathic rats. This action may be associated with changes in the activation and inactivation kinetics of Ca<sup>2&#x002B;</sup> channels, as well as an increase in the proportion of N-type Ca<sup>2&#x002B;</sup> currents. The different effects of GBP on HVA-Ca<sup>2&#x002B;</sup> currents in axotomized vs. adjacent neurons may depend on the particular neuropathological condition or inflammatory circumstances induced by peripheral nerve injury.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>The present study was supported by the Scientific Research Fund of China Post doctorates of the Chinese Government (nos. 20080431417 and 200902694).</p>
</ack>
<ref-list>
<title>References</title>
<ref id="b1-etm-0-0-4071"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costigan</surname><given-names>M</given-names></name><name><surname>Scholz</surname><given-names>J</given-names></name><name><surname>Woolf</surname><given-names>CJ</given-names></name></person-group><article-title>Neuropathic Pain: A maladaptive response of the nervous system to damage</article-title><source>Annu Rev Neurosci</source><volume>32</volume><fpage>1</fpage><lpage>32</lpage><year>2009</year><pub-id pub-id-type="doi">10.1146/annurev.neuro.051508.135531</pub-id><pub-id pub-id-type="pmid">19400724</pub-id></element-citation></ref>
<ref id="b2-etm-0-0-4071"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sommer</surname><given-names>C</given-names></name></person-group><article-title>Neuropathic pain: Pathophysiology, assessment and therapy</article-title><source>Schmerz</source><volume>27</volume><fpage>619</fpage><lpage>632</lpage><year>2013</year><comment>(In German)</comment><pub-id pub-id-type="doi">10.1007/s00482-013-1344-8</pub-id><pub-id pub-id-type="pmid">24217854</pub-id></element-citation></ref>
<ref id="b3-etm-0-0-4071"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laedermann</surname><given-names>CJ</given-names></name><name><surname>Pertin</surname><given-names>M</given-names></name><name><surname>Suter</surname><given-names>MR</given-names></name><name><surname>Decosterd</surname><given-names>I</given-names></name></person-group><article-title>Voltage-gated sodium channel expression in mouse DRG after SNI leads to re-evaluation of projections of injured fibers</article-title><source>Mol Pain</source><volume>10</volume><fpage>19</fpage><year>2014</year><pub-id pub-id-type="doi">10.1186/1744-8069-10-19</pub-id><pub-id pub-id-type="pmid">24618114</pub-id></element-citation></ref>
<ref id="b4-etm-0-0-4071"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsantoulas</surname><given-names>C</given-names></name><name><surname>Zhu</surname><given-names>L</given-names></name><name><surname>Shaifta</surname><given-names>Y</given-names></name><name><surname>Grist</surname><given-names>J</given-names></name><name><surname>Ward</surname><given-names>JP</given-names></name><name><surname>Raouf</surname><given-names>R</given-names></name><name><surname>Michael</surname><given-names>GJ</given-names></name><name><surname>McMahon</surname><given-names>SB</given-names></name></person-group><article-title>Sensory neuron downregulation of the Kv9.1 potassium channel subunit mediates neuropathic pain following nerve injury</article-title><source>J Neurosci</source><volume>32</volume><fpage>17502</fpage><lpage>17513</lpage><year>2012</year><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3561-12.2012</pub-id><pub-id pub-id-type="pmid">23197740</pub-id></element-citation></ref>
<ref id="b5-etm-0-0-4071"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sapunar</surname><given-names>D</given-names></name><name><surname>Ljubkovic</surname><given-names>M</given-names></name><name><surname>Lirk</surname><given-names>P</given-names></name><name><surname>McCallum</surname><given-names>JB</given-names></name><name><surname>Hogan</surname><given-names>QH</given-names></name></person-group><article-title>Distinct membrane effects of spinal nerve ligation on injured and adjacent dorsal root ganglion neurons in rats</article-title><source>Anesthesiology</source><volume>103</volume><fpage>360</fpage><lpage>376</lpage><year>2005</year><pub-id pub-id-type="doi">10.1097/00000542-200508000-00020</pub-id><pub-id pub-id-type="pmid">16052119</pub-id></element-citation></ref>
<ref id="b6-etm-0-0-4071"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>C</given-names></name><name><surname>Shu</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Yao</surname><given-names>H</given-names></name><name><surname>Greenquist</surname><given-names>KW</given-names></name><name><surname>White</surname><given-names>FA</given-names></name><name><surname>LaMotte</surname><given-names>RH</given-names></name></person-group><article-title>Similar electrophysiological changes in axotomized and neighboring intact dorsal root ganglion neurons</article-title><source>J Neurophysiol</source><volume>89</volume><fpage>1588</fpage><lpage>1602</lpage><year>2003</year><pub-id pub-id-type="doi">10.1152/jn.00855.2002</pub-id><pub-id pub-id-type="pmid">12612024</pub-id></element-citation></ref>
<ref id="b7-etm-0-0-4071"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>YF</given-names></name><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Henry</surname><given-names>JL</given-names></name></person-group><article-title>Changes in functional properties of A-type but not C-type sensory neurons in vivo in a rat model of peripheral neuropathy</article-title><source>J Pain Res</source><volume>5</volume><fpage>175</fpage><lpage>192</lpage><year>2012</year><pub-id pub-id-type="pmid">22792004</pub-id></element-citation></ref>
<ref id="b8-etm-0-0-4071"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Felix</surname><given-names>R</given-names></name><name><surname>Calder&#x00F3;n-Rivera</surname><given-names>A</given-names></name><name><surname>Andrade</surname><given-names>A</given-names></name></person-group><article-title>Regulation of high-voltage-activated Ca2&#x002B; channel function, trafficking, and membrane stability by auxiliary subunits</article-title><source>Wiley Interdiscip Rev Membr Transp Signal</source><volume>2</volume><fpage>207</fpage><lpage>220</lpage><year>2013</year><pub-id pub-id-type="doi">10.1002/wmts.93</pub-id><pub-id pub-id-type="pmid">24949251</pub-id></element-citation></ref>
<ref id="b9-etm-0-0-4071"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>C</given-names></name><name><surname>Luo</surname><given-names>ZD</given-names></name></person-group><article-title>Electrophysiological characterization of spinal neuron sensitization by elevated calcium channel alpha-2-delta-1 subunit protein</article-title><source>Eur J Pain</source><volume>18</volume><fpage>649</fpage><lpage>658</lpage><year>2014</year><pub-id pub-id-type="doi">10.1002/j.1532-2149.2013.00416.x</pub-id><pub-id pub-id-type="pmid">24151064</pub-id></element-citation></ref>
<ref id="b10-etm-0-0-4071"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hooker</surname><given-names>BA</given-names></name><name><surname>Tobon</surname><given-names>G</given-names></name><name><surname>Baker</surname><given-names>SJ</given-names></name><name><surname>Zhu</surname><given-names>C</given-names></name><name><surname>Hesterman</surname><given-names>J</given-names></name><name><surname>Schmidt</surname><given-names>K</given-names></name><name><surname>Rajagovindan</surname><given-names>R</given-names></name><name><surname>Chandran</surname><given-names>P</given-names></name><name><surname>Joshi</surname><given-names>SK</given-names></name><name><surname>Bannon</surname><given-names>AW</given-names></name><etal/></person-group><article-title>Gabapentin-induced pharmacodynamic effects in the spinal nerve ligation model of neuropathic pain</article-title><source>Eur J Pain</source><volume>18</volume><fpage>223</fpage><lpage>237</lpage><year>2014</year><pub-id pub-id-type="doi">10.1002/j.1532-2149.2013.00364.x</pub-id><pub-id pub-id-type="pmid">23857727</pub-id></element-citation></ref>
<ref id="b11-etm-0-0-4071"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kukkar</surname><given-names>A</given-names></name><name><surname>Bali</surname><given-names>A</given-names></name><name><surname>Singh</surname><given-names>N</given-names></name><name><surname>Jaggi</surname><given-names>AS</given-names></name></person-group><article-title>Implications and mechanism of action of gabapentin in neuropathic pain</article-title><source>Arch Pharm Res</source><volume>36</volume><fpage>237</fpage><lpage>251</lpage><year>2013</year><pub-id pub-id-type="doi">10.1007/s12272-013-0057-y</pub-id><pub-id pub-id-type="pmid">23435945</pub-id></element-citation></ref>
<ref id="b12-etm-0-0-4071"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Chung</surname><given-names>JM</given-names></name></person-group><article-title>An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat</article-title><source>Pain</source><volume>50</volume><fpage>355</fpage><lpage>363</lpage><year>1992</year><pub-id pub-id-type="doi">10.1016/0304-3959(92)90041-9</pub-id><pub-id pub-id-type="pmid">1333581</pub-id></element-citation></ref>
<ref id="b13-etm-0-0-4071"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>Y</given-names></name><name><surname>Yoon</surname><given-names>YW</given-names></name><name><surname>Na</surname><given-names>HS</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Chung</surname><given-names>JM</given-names></name></person-group><article-title>Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain</article-title><source>Pain</source><volume>59</volume><fpage>369</fpage><lpage>376</lpage><year>1994</year><pub-id pub-id-type="doi">10.1016/0304-3959(94)90023-X</pub-id><pub-id pub-id-type="pmid">7708411</pub-id></element-citation></ref>
<ref id="b14-etm-0-0-4071"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harper</surname><given-names>AA</given-names></name><name><surname>Lawson</surname><given-names>SN</given-names></name></person-group><article-title>Conduction velocity is related to morphological cell type in rat dorsal root ganglion neurons</article-title><source>J Physiol</source><volume>359</volume><fpage>31</fpage><lpage>46</lpage><year>1985</year><pub-id pub-id-type="doi">10.1113/jphysiol.1985.sp015573</pub-id><pub-id pub-id-type="pmid">3999040</pub-id></element-citation></ref>
<ref id="b15-etm-0-0-4071"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCallum</surname><given-names>JB</given-names></name><name><surname>Kwok</surname><given-names>WM</given-names></name><name><surname>Sapunar</surname><given-names>D</given-names></name><name><surname>Fuchs</surname><given-names>A</given-names></name><name><surname>Hogan</surname><given-names>QH</given-names></name></person-group><article-title>Painful peripheral nerve injury decreases calcium current in axotomized sensory neurons</article-title><source>Anesthesiology</source><volume>105</volume><fpage>160</fpage><lpage>168</lpage><year>2006</year><pub-id pub-id-type="doi">10.1097/00000542-200607000-00026</pub-id><pub-id pub-id-type="pmid">16810008</pub-id></element-citation></ref>
<ref id="b16-etm-0-0-4071"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hogan</surname><given-names>QH</given-names></name></person-group><article-title>Role of decreased sensory neuron membrane calcium currents in the genesis of neuropathic pain</article-title><source>Croat Med J</source><volume>48</volume><fpage>9</fpage><lpage>21</lpage><year>2007</year><pub-id pub-id-type="pmid">17309135</pub-id></element-citation></ref>
<ref id="b17-etm-0-0-4071"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baccei</surname><given-names>ML</given-names></name><name><surname>Kocsis</surname><given-names>JD</given-names></name></person-group><article-title>Voltage-gated calcium currents in axotomized adult rat cutaneous afferent neurons</article-title><source>J Neurophysiol</source><volume>83</volume><fpage>2227</fpage><lpage>2238</lpage><year>2000</year><pub-id pub-id-type="pmid">10758131</pub-id></element-citation></ref>
<ref id="b18-etm-0-0-4071"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCallum</surname><given-names>JB</given-names></name><name><surname>Kwok</surname><given-names>WM</given-names></name><name><surname>Mynlieff</surname><given-names>M</given-names></name><name><surname>Bosnjak</surname><given-names>ZJ</given-names></name><name><surname>Hogan</surname><given-names>QH</given-names></name></person-group><article-title>Loss of T-type calcium current in sensory neurons of rats with neuropathic pain</article-title><source>Anesthesiology</source><volume>98</volume><fpage>209</fpage><lpage>216</lpage><year>2003</year><pub-id pub-id-type="doi">10.1097/00000542-200301000-00032</pub-id><pub-id pub-id-type="pmid">12502999</pub-id></element-citation></ref>
<ref id="b19-etm-0-0-4071"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blair</surname><given-names>NT</given-names></name><name><surname>Bean</surname><given-names>BP</given-names></name></person-group><article-title>Roles of tetrodotoxin (TTX)-sensitive Na&#x002B; current, TTX-resistant Na&#x002B; current, and Ca2&#x002B; current in the action potentials of nociceptive sensory neurons</article-title><source>J Neurosci</source><volume>22</volume><fpage>10277</fpage><lpage>10290</lpage><year>2002</year><pub-id pub-id-type="pmid">12451128</pub-id></element-citation></ref>
<ref id="b20-etm-0-0-4071"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lirk</surname><given-names>P</given-names></name><name><surname>Poroli</surname><given-names>M</given-names></name><name><surname>Rigaud</surname><given-names>M</given-names></name><name><surname>Fuchs</surname><given-names>A</given-names></name><name><surname>Fillip</surname><given-names>P</given-names></name><name><surname>Huang</surname><given-names>CY</given-names></name><name><surname>Ljubkovic</surname><given-names>M</given-names></name><name><surname>Sapunar</surname><given-names>D</given-names></name><name><surname>Hogan</surname><given-names>Q</given-names></name></person-group><article-title>Modulators of calcium influx regulate membrane excitability in rat dorsal root ganglion neurons</article-title><source>Anesth Analg</source><volume>107</volume><fpage>673</fpage><lpage>685</lpage><year>2008</year><pub-id pub-id-type="doi">10.1213/ane.0b013e31817b7a73</pub-id><pub-id pub-id-type="pmid">18633052</pub-id></element-citation></ref>
<ref id="b21-etm-0-0-4071"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jang</surname><given-names>JH</given-names></name><name><surname>Lee</surname><given-names>BH</given-names></name><name><surname>Nam</surname><given-names>TS</given-names></name><name><surname>Kim</surname><given-names>JW</given-names></name><name><surname>Kim</surname><given-names>DW</given-names></name><name><surname>Leem</surname><given-names>JW</given-names></name></person-group><article-title>Peripheral contributions to the mechanical hyperalgesia following a lumbar 5 spinal nerve lesion in rats</article-title><source>Neuroscience</source><volume>165</volume><fpage>221</fpage><lpage>232</lpage><year>2010</year><pub-id pub-id-type="doi">10.1016/j.neuroscience.2009.09.082</pub-id><pub-id pub-id-type="pmid">19804816</pub-id></element-citation></ref>
<ref id="b22-etm-0-0-4071"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Stephens</surname><given-names>GJ</given-names></name></person-group><article-title>Effects of neuropathy on high-voltage-activated Ca (2&#x002B;) current in sensory neurones</article-title><source>Cell Calcium</source><volume>46</volume><fpage>248</fpage><lpage>256</lpage><year>2009</year><pub-id pub-id-type="doi">10.1016/j.ceca.2009.08.001</pub-id><pub-id pub-id-type="pmid">19726083</pub-id></element-citation></ref>
<ref id="b23-etm-0-0-4071"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>XD</given-names></name><name><surname>Zhu</surname><given-names>MM</given-names></name><name><surname>Chen</surname><given-names>XD</given-names></name><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Xiao</surname><given-names>H</given-names></name><name><surname>Xu</surname><given-names>JG</given-names></name><name><surname>Duan</surname><given-names>ML</given-names></name></person-group><article-title>Effects of gabapentin on high-voltage-activated calcium current in dorsal root ganglion neurons in rats</article-title><source>Zhonghua Yi Xue Za Zhi</source><volume>91</volume><fpage>1713</fpage><lpage>1717</lpage><year>2011</year><comment>(In Chinese)</comment><pub-id pub-id-type="pmid">21914324</pub-id></element-citation></ref>
<ref id="b24-etm-0-0-4071"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hogan</surname><given-names>QH</given-names></name><name><surname>McCallum</surname><given-names>JB</given-names></name><name><surname>Sarantopoulos</surname><given-names>C</given-names></name><name><surname>Aason</surname><given-names>M</given-names></name><name><surname>Mynlieff</surname><given-names>M</given-names></name><name><surname>Kwok</surname><given-names>WM</given-names></name><name><surname>Bosnjak</surname><given-names>ZJ</given-names></name></person-group><article-title>Painful neuropathy decreases membrane calcium current in mammalian primary afferent neurons</article-title><source>Pain</source><volume>86</volume><fpage>43</fpage><lpage>53</lpage><year>2000</year><pub-id pub-id-type="doi">10.1016/S0304-3959(99)00313-9</pub-id><pub-id pub-id-type="pmid">10779659</pub-id></element-citation></ref>
<ref id="b25-etm-0-0-4071"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>DS</given-names></name><name><surname>Yoon</surname><given-names>CH</given-names></name><name><surname>Lee</surname><given-names>SJ</given-names></name><name><surname>Park</surname><given-names>SY</given-names></name><name><surname>Yoo</surname><given-names>HJ</given-names></name><name><surname>Cho</surname><given-names>HJ</given-names></name></person-group><article-title>Changes in voltage-gated calcium channel alpha(1) gene expression in rat dorsal root ganglia following peripheral nerve injury</article-title><source>Brain Res Mol Brain Res</source><volume>96</volume><fpage>151</fpage><lpage>156</lpage><year>2001</year><pub-id pub-id-type="doi">10.1016/S0169-328X(01)00285-6</pub-id><pub-id pub-id-type="pmid">11731020</pub-id></element-citation></ref>
<ref id="b26-etm-0-0-4071"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rycroft</surname><given-names>BK</given-names></name><name><surname>Vikman</surname><given-names>KS</given-names></name><name><surname>Christie</surname><given-names>MJ</given-names></name></person-group><article-title>Inflammation reduces the contribution of N-type calcium channels to primary afferent synaptic transmission onto NK1 receptor-positive lamina I neurons in the rat dorsal horn</article-title><source>J Physiol</source><volume>580</volume><fpage>883</fpage><lpage>894</lpage><year>2007</year><pub-id pub-id-type="doi">10.1113/jphysiol.2006.125880</pub-id><pub-id pub-id-type="pmid">17303639</pub-id></element-citation></ref>
<ref id="b27-etm-0-0-4071"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>ZD</given-names></name><name><surname>Calcutt</surname><given-names>NA</given-names></name><name><surname>Higuera</surname><given-names>ES</given-names></name><name><surname>Valder</surname><given-names>CR</given-names></name><name><surname>Song</surname><given-names>YH</given-names></name><name><surname>Svensson</surname><given-names>CI</given-names></name><name><surname>Myers</surname><given-names>RR</given-names></name></person-group><article-title>Injury type-specific calcium channel alpha 2 delta-1 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin</article-title><source>J Pharmacol Exp Ther</source><volume>303</volume><fpage>1199</fpage><lpage>1205</lpage><year>2002</year><pub-id pub-id-type="doi">10.1124/jpet.102.041574</pub-id><pub-id pub-id-type="pmid">12438544</pub-id></element-citation></ref>
<ref id="b28-etm-0-0-4071"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gauchan</surname><given-names>P</given-names></name><name><surname>Andoh</surname><given-names>T</given-names></name><name><surname>Ikeda</surname><given-names>K</given-names></name><name><surname>Fujita</surname><given-names>M</given-names></name><name><surname>Sasaki</surname><given-names>A</given-names></name><name><surname>Kato</surname><given-names>A</given-names></name><name><surname>Kuraishi</surname><given-names>Y</given-names></name></person-group><article-title>Mechanical allodynia induced by paclitaxel, oxaliplatin and vincristine: Different effectiveness of gabapentin and different expression of voltage-dependent calcium channel alpha(2)delta-1 subunit</article-title><source>Biol Pharm Bull</source><volume>32</volume><fpage>732</fpage><lpage>734</lpage><year>2009</year><pub-id pub-id-type="doi">10.1248/bpb.32.732</pub-id><pub-id pub-id-type="pmid">19336915</pub-id></element-citation></ref>
<ref id="b29-etm-0-0-4071"><label>29</label><element-citation publication-type="book"><collab collab-type="corp-author">Gabapentin for Adults with Neuropathic Pain</collab><source>A Review of the Clinical Evidence and Guidelines</source><publisher-loc>Ottawa (ON)</publisher-loc><publisher-name>Canadian Agency for Drugs and Technologies in Health</publisher-name><year>2014</year></element-citation></ref>
<ref id="b30-etm-0-0-4071"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarantopoulos</surname><given-names>C</given-names></name><name><surname>McCallum</surname><given-names>B</given-names></name><name><surname>Kwok</surname><given-names>WM</given-names></name><name><surname>Hogan</surname><given-names>Q</given-names></name></person-group><article-title>Gabapentin decreases membrane calcium currents in injured as well as in control mammalian primary afferent neurons</article-title><source>Reg Anesth Pain Med</source><volume>27</volume><fpage>47</fpage><lpage>57</lpage><year>2002</year><pub-id pub-id-type="doi">10.1053/rapm.2002.29124</pub-id><pub-id pub-id-type="pmid">11799505</pub-id></element-citation></ref>
<ref id="b31-etm-0-0-4071"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sutton</surname><given-names>KG</given-names></name><name><surname>Martin</surname><given-names>DJ</given-names></name><name><surname>Pinnock</surname><given-names>RD</given-names></name><name><surname>Lee</surname><given-names>K</given-names></name><name><surname>Scott</surname><given-names>RH</given-names></name></person-group><article-title>Gabapentin inhibits high-threshold calcium channel currents in cultured rat dorsal root ganglion neurones</article-title><source>Br J Pharmacol</source><volume>135</volume><fpage>257</fpage><lpage>265</lpage><year>2002</year><pub-id pub-id-type="doi">10.1038/sj.bjp.0704439</pub-id><pub-id pub-id-type="pmid">11786502</pub-id></element-citation></ref>
<ref id="b32-etm-0-0-4071"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boroujerdi</surname><given-names>A</given-names></name><name><surname>Zeng</surname><given-names>J</given-names></name><name><surname>Sharp</surname><given-names>K</given-names></name><name><surname>Kim</surname><given-names>D</given-names></name><name><surname>Steward</surname><given-names>O</given-names></name><name><surname>Luo</surname><given-names>ZD</given-names></name></person-group><article-title>Calcium channel alpha-2-delta-1 protein upregulation in dorsal spinal cord mediates spinal cord injury-induced neuropathic pain states</article-title><source>Pain</source><volume>152</volume><fpage>649</fpage><lpage>655</lpage><year>2011</year><pub-id pub-id-type="doi">10.1016/j.pain.2010.12.014</pub-id><pub-id pub-id-type="pmid">21239111</pub-id></element-citation></ref>
<ref id="b33-etm-0-0-4071"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benedikt</surname><given-names>Nimmervoll</given-names></name></person-group><source>The function of the Ca2&#x002B; channel &#x03B1;2&#x03B4; subunits in synaptic release in hippocampal neurons</source></element-citation></ref>
<ref id="b34-etm-0-0-4071"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lana</surname><given-names>B</given-names></name><name><surname>Schlick</surname><given-names>B</given-names></name><name><surname>Martin</surname><given-names>S</given-names></name><name><surname>Pratt</surname><given-names>WS</given-names></name><name><surname>Page</surname><given-names>KM</given-names></name><name><surname>Goncalves</surname><given-names>L</given-names></name><name><surname>Rahman</surname><given-names>W</given-names></name><name><surname>Dickenson</surname><given-names>AH</given-names></name><name><surname>Bauer</surname><given-names>CS</given-names></name><name><surname>Dolphin</surname><given-names>AC</given-names></name></person-group><article-title>Differential upregulation in DRG neurons of an &#x03B1;2&#x03B4;-1 splice variant with a lower affinity for gabapentin after peripheral sensory nerve injury</article-title><source>Pain</source><volume>155</volume><fpage>522</fpage><lpage>533</lpage><year>2014</year><pub-id pub-id-type="doi">10.1016/j.pain.2013.12.001</pub-id><pub-id pub-id-type="pmid">24315988</pub-id></element-citation></ref>
<ref id="b35-etm-0-0-4071"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>RA</given-names></name><name><surname>Ringkamp</surname><given-names>M</given-names></name></person-group><article-title>A role for uninjured afferents in neuropathic pain</article-title><source>Sheng Li Xue Bao</source><volume>60</volume><fpage>605</fpage><lpage>609</lpage><year>2008</year><pub-id pub-id-type="pmid">18958368</pub-id></element-citation></ref>
</ref-list>
</back>
<floats-group>
<fig id="f1-etm-0-0-4071" position="float">
<label>Figure 1.</label>
<caption><p>Withdrawal responses of Ipsi. and Cont. feet following mechanical and thermal stimulation. (A) Mean threshold for withdrawal following Von Frey stimulation with different bending forces. (B) Thresholds of paw withdrawal in response to mechanical stimuli. (C) Mean latencies of thermal withdrawal responses. Values are expressed as the mean &#x00B1; standard deviation. <sup>#</sup>P&#x003C;0.05 and <sup>##</sup>P&#x003C;0.01, Pre vs. Pod (paired <italic>t</italic>-test); &#x002A;P&#x003C;0.05 and &#x002A;&#x002A;P&#x003C;0.01, Ipsi. foot responses in SNL (n=16) vs. sham group (n=7) (analysis of variance). Pre, pre-operative period; Pod, post-operative days; Ipsi., paw ipsilateral to surgery; Cont., paw contralateral to surgery; PWMT, paw withdrawal mechanical threshold; PAWTL, paw withdrawal time latency; SNL, spinal nerve ligation; sham, sham operation.</p></caption>
<graphic xlink:href="etm-13-03-0851-g00.tiff"/>
</fig>
<fig id="f2-etm-0-0-4071" position="float">
<label>Figure 2.</label>
<caption><p>HVA calcium channel currents. (A) Inward currents were recorded with the command voltage between-70 and &#x002B;40 mV with 80-msec intervals and successive increments of 10 mV, as well as a VH of &#x2212;90 mV. (B) The I&#x2013;V curve was fit using a Boltzmann equation. The ICa density was the Ca<sup>2&#x002B;</sup> channel current standardized by the membrane capacitance. (C) Inward currents in the same cell were recorded using the same steps of command voltages as in A in the presence of 200 &#x00B5;mol/l CdCl<sub>2</sub>. HVA, high-voltage activation; ICa, Ca<sup>2&#x002B;</sup> currency; V<sub>H</sub>, holding potential; I&#x2013;V, current-voltage, pA/pF, peak current density.</p></caption>
<graphic xlink:href="etm-13-03-0851-g01.tiff"/>
</fig>
<fig id="f3-etm-0-0-4071" position="float">
<label>Figure 3.</label>
<caption><p>ICa density-voltage associations in control, adjacent and axotomized neurons were examined by the application of 80-msec voltage steps to various test potentials between &#x2212;70 and &#x002B;40 mV in 10-mV steps with 5-sec intervals from a holding potential of &#x2212;90 mV. The ICa of adjacent (104&#x00B1;17 pA/pF; n=5) and axotomized neurons (75&#x00B1;17 pA/pF; n=8) was significantly lower than that of control neurons (144&#x00B1;24 pA/pF; n=7; P&#x003C;0.05). In addition, the ICa of axotomized neurons was lower than that of adjacent neurons (P&#x003C;0.05). The activation voltage of ICa in control and adjacent neurons was 0 mV, while that in axotomized neurons was &#x2212;10 mV. Values are expressed as the mean &#x00B1; standard deviation. &#x002A;P&#x003C;0.05 vs. control neurons. <sup>#</sup>P&#x003C;0.05 regarding adjacent vs. axotomized neurons. ICa, Ca<sup>2&#x002B;</sup> density; pA/pF, peak current density; C, control; SNL, spinal nerve ligation; L4, adjacent neurons; L5, axotomized neurons.</p></caption>
<graphic xlink:href="etm-13-03-0851-g02.tiff"/>
</fig>
<fig id="f4-etm-0-0-4071" position="float">
<label>Figure 4.</label>
<caption><p>(A) Activation. The membrane V<sub>H</sub> was set at &#x2212;90 mV, calcium currents were elicited by a series of command voltages ranging from &#x2212;70 to &#x002B;40 mV with successive increments of 10 mV with 80-msec intervals. (B) Steady-state inactivation. Ca<sup>2&#x002B;</sup> currents were generated by the membrane VH at &#x2212;90 mV for 10 msec, immediately followed by a series of command voltages from &#x2212;70 to &#x002B;20 mV with successive increments of 10 mV at 500-msec intervals. Subsequently, command voltages of &#x2212;10 mV were applied at 80-msec intervals. (C) Activation curves were fitted using the Boltzmann equation (control neurons, n=10; adjacent neurons, n=5; axotomized neurons, n=8). A depolarized shift was observed in adjacent and axotomized neurons. Va1/2 of three groups was compared. &#x002A;P&#x003C;0.05 vs. control neurons. <sup>#</sup>P&#x003C;0.05 regarding axotomized vs. adjacent neurons. (D) Inactivation curves were fitted using the Boltzmann equation (control neurons; n=6; adjacent neurons, n=6; axotomized neurons, n=7). Vi1/2 of three groups was compared. Values are expressed as the mean &#x00B1; standard deviation. C, control; SNL, spinal nerve ligation; V<sub>H</sub>, holding potential; G, conductance; I, current; L4, adjacent neurons; L5, axotomized neurons.</p></caption>
<graphic xlink:href="etm-13-03-0851-g03.tiff"/>
</fig>
<fig id="f5-etm-0-0-4071" position="float">
<label>Figure 5.</label>
<caption><p>HVA-Ca<sup>2&#x002B;</sup> current activation and steady-state inactivation curves of control, adjacent and axotomized neurons in the absence or presence of 100 &#x00B5;mol/l GBP. (A) Activation (n=10) and steady-state inactivation (n=6) curves shifted towards a hyperpolarization direction in control neurons, which reduced the &#x2018;window currents&#x2019;, in the presence of 100 &#x00B5;mol/l GBP. Va<sub>1/2</sub> decreased from &#x2212;16.23&#x00B1;1.92 to &#x2212;19.69&#x00B1;1.07 mV with GBP added (P&#x003C;0.05); Vi<sub>1/2</sub> was inactivated at &#x2212;31.93&#x00B1;1.03 mV vs. &#x2212;38.78&#x00B1;2.05 (P&#x003C;0.05). (B) A hyperpolarized shift was observed in activation (n=5) and steady-state inactivation (n=6) curves of adjacent neurons; however, &#x2018;window currents&#x2019; remained unchanged in the presence of 100 &#x00B5;mol/l GBP. Va<sub>1/2</sub> decreased from &#x2212;18.03&#x00B1;0.37 to &#x2212;21.73&#x00B1;0.64 mV (P&#x003C;0.05) with the addition of GBP; Vi<sub>1/2</sub> was inactivated at &#x2212;31.45&#x00B1;1.87 mV vs. &#x2212;36.22&#x00B1;2.80 mV (P&#x003C;0.05). (C) Activation (n=8) and steady-state inactivation (n=7) curves in axotomized neurons, showing reduced &#x2018;window currents&#x2019; in the presence of 100 &#x00B5;mol/l GBP. Compared without using GBP, after adding GBP, Va<sub>1/2</sub> and Vi<sub>1/2</sub> decreased from &#x2212;20.73&#x00B1;0.33 and &#x2212;32.73&#x00B1;1.37 mV towards &#x2212;23.94&#x00B1;0.15 mV (P&#x003C;0.05) and &#x2212;44.23&#x00B1;2.30 mV (P&#x003C;0.05). Values are expressed as the mean &#x00B1; standard deviation. GBP, gabapentin; HVA, high-voltage activation; Va<sub>1/2</sub>, voltage at the half maximal activation current; Vi<sub>1/2</sub>, voltage at the half maximal inactivation current; I, current; G, conductance.</p></caption>
<graphic xlink:href="etm-13-03-0851-g04.tif"/>
</fig>
<fig id="f6-etm-0-0-4071" position="float">
<label>Figure 6.</label>
<caption><p>Sub-types of HVA-Ca<sup>2&#x002B;</sup> currents identified by application of specific channel blockers. (A) To individually assess various types of calcium channels present in the same cell, 20 &#x00B5;mol/l nifedipine (L-type Ca<sup>2&#x002B;</sup>-specific channel blocker), 2 &#x00B5;mol/l &#x03C9;-conotoxin MVIIC (P/Q-type Ca<sup>2&#x002B;</sup> channel-specific blocker) and 2 &#x00B5;mol/l &#x03C9;-conotoxin MVIIA (N-type Ca<sup>2&#x002B;</sup> channel-specific blocker) were applied to the bath in sequence when stable currents were reached. (B) Fraction changes of each sub-type (L, N, P/Q) Ca<sup>2&#x002B;</sup> channel current over the total HVA-Ca<sup>2&#x002B;</sup> peak currents in control, adjacent and axotomized neurons. Values are expressed as the mean &#x00B1; standard deviation (n=10). &#x002A;P&#x003C;0.05 vs. control neurons (ANOVA); <sup>#</sup>P&#x003C;0.05 regarding axotomized vs. adjacent neurons (ANOVA). HVA, high-voltage activation; ANOVA, analysis of variance; SNL, spinal nerve ligation; L4, adjacent neurons; L5, axotomized neurons.</p></caption>
<graphic xlink:href="etm-13-03-0851-g05.tif"/>
</fig>
<table-wrap id="tI-etm-0-0-4071" position="float">
<label>Table I.</label>
<caption><p>Comparison of peak current inhibition rates (&#x0025;) among the three groups at various gabapentin concentrations.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th/>
<th align="center" valign="bottom" colspan="5">Gabapentin concentration (&#x00B5;mol/l)</th>
</tr>
<tr>
<th/>
<th align="center" valign="bottom" colspan="5"><hr/></th>
</tr>
<tr>
<th align="left" valign="bottom">Group</th>
<th align="center" valign="bottom">0.1</th>
<th align="center" valign="bottom">1</th>
<th align="center" valign="bottom">10</th>
<th align="center" valign="bottom">100</th>
<th align="center" valign="bottom">300</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">C (n=7)</td>
<td align="center" valign="top">10.8&#x00B1;1.5</td>
<td align="center" valign="top">12.8&#x00B1;1.8</td>
<td align="center" valign="top">15.6&#x00B1;2.1<sup><xref rid="tfn2-etm-0-0-4071" ref-type="table-fn">a</xref></sup></td>
<td align="center" valign="top">27.3&#x00B1;2.9<sup><xref rid="tfn2-etm-0-0-4071" ref-type="table-fn">a</xref>,<xref rid="tfn3-etm-0-0-4071" ref-type="table-fn">b</xref></sup></td>
<td align="center" valign="top">28.1&#x00B1;3.3<sup><xref rid="tfn2-etm-0-0-4071" ref-type="table-fn">a</xref>,<xref rid="tfn3-etm-0-0-4071" ref-type="table-fn">b</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">SNL-L<sub>4</sub> (n=5)</td>
<td align="center" valign="top">10.5&#x00B1;1.6</td>
<td align="center" valign="top">12.2&#x00B1;2.1</td>
<td align="center" valign="top">16.0&#x00B1;1.9<sup><xref rid="tfn2-etm-0-0-4071" ref-type="table-fn">a</xref></sup></td>
<td align="center" valign="top">26.9&#x00B1;2.0<sup><xref rid="tfn2-etm-0-0-4071" ref-type="table-fn">a</xref>,<xref rid="tfn3-etm-0-0-4071" ref-type="table-fn">b</xref></sup></td>
<td align="center" valign="top">27.4&#x00B1;2.3<sup><xref rid="tfn2-etm-0-0-4071" ref-type="table-fn">a</xref>,<xref rid="tfn3-etm-0-0-4071" ref-type="table-fn">b</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">SNL-L<sub>5</sub> (n=8)</td>
<td align="center" valign="top">11.4&#x00B1;1.5</td>
<td align="center" valign="top">12.9&#x00B1;1.0</td>
<td align="center" valign="top">18.5&#x00B1;1.7<sup><xref rid="tfn2-etm-0-0-4071" ref-type="table-fn">a</xref>,<xref rid="tfn4-etm-0-0-4071" ref-type="table-fn">c</xref>,<xref rid="tfn5-etm-0-0-4071" ref-type="table-fn">d</xref></sup></td>
<td align="center" valign="top">32.0&#x00B1;2.6<sup><xref rid="tfn2-etm-0-0-4071" ref-type="table-fn">a</xref>&#x2013;<xref rid="tfn5-etm-0-0-4071" ref-type="table-fn">d</xref></sup></td>
<td align="center" valign="top">32.7&#x00B1;2.8<sup><xref rid="tfn2-etm-0-0-4071" ref-type="table-fn">a</xref>&#x2013;<xref rid="tfn5-etm-0-0-4071" ref-type="table-fn">d</xref></sup></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn1-etm-0-0-4071"><p>Values are expressed as the mean &#x00B1; standard deviation (n=8).</p></fn>
<fn id="tfn2-etm-0-0-4071"><label>a</label><p>P&#x003C;0.05, intragroup comparison between 0.1 and 1 &#x00B5;mol/l</p></fn>
<fn id="tfn3-etm-0-0-4071"><label>b</label><p>P&#x003C;0.05, compared with 10 &#x00B5;mol/l of the same group</p></fn>
<fn id="tfn4-etm-0-0-4071"><label>c</label><p>P&#x003C;0.05, compared with the C group of the same concentration</p></fn>
<fn id="tfn5-etm-0-0-4071"><label>d</label><p>P&#x003C;0.05, compared with the SNL-L4 group at the same concentration. SNL, spinal nerve ligation; L4, adjacent neurons; L5, axotomized neurons; C, control.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="tII-etm-0-0-4071" position="float">
<label>Table II.</label>
<caption><p>Sensitive Ca<sup>2&#x002B;</sup> current ratios (&#x0025;) of each channel sub-type (L, P/Q and N) among the three groups.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th/>
<th align="center" valign="bottom" colspan="3">HVA-Ca<sup>2&#x002B;</sup> subtype</th>
</tr>
<tr>
<th/>
<th align="center" valign="bottom" colspan="3"><hr/></th>
</tr>
<tr>
<th align="left" valign="bottom">Group</th>
<th align="center" valign="bottom">L</th>
<th align="center" valign="bottom">P/Q</th>
<th align="center" valign="bottom">N</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">C</td>
<td align="center" valign="top">35.2&#x00B1;4.3</td>
<td align="center" valign="top">43.4&#x00B1;3.5</td>
<td align="center" valign="top">68.8&#x00B1;4.5</td>
</tr>
<tr>
<td align="left" valign="top">SNL-L4</td>
<td align="center" valign="top">34.9&#x00B1;3.7</td>
<td align="center" valign="top">43.6&#x00B1;4.7</td>
<td align="center" valign="top">69.7&#x00B1;3.3</td>
</tr>
<tr>
<td align="left" valign="top">SNL-L5</td>
<td align="center" valign="top">32.5&#x00B1;3.4</td>
<td align="center" valign="top">45.6&#x00B1;4.6</td>
<td align="center" valign="top">81.0&#x00B1;2.8<sup><xref rid="tfn7-etm-0-0-4071" ref-type="table-fn">a</xref>,<xref rid="tfn8-etm-0-0-4071" ref-type="table-fn">b</xref></sup></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn6-etm-0-0-4071"><p>Values are expressed as the mean &#x00B1; standard deviation (n=10).</p></fn>
<fn id="tfn7-etm-0-0-4071"><label>a</label><p>P&#x003C;0.05, compared with the same Ca<sup>2&#x002B;</sup> current sub-type of the C group</p></fn>
<fn id="tfn8-etm-0-0-4071"><label>b</label><p>P&#x003C;0.05, compared with the same Ca<sup>2&#x002B;</sup> current sub-type of the SNL-L<sub>4</sub> group. SNL, spinal nerve ligation; L4, adjacent neurons; L5, axotomized neurons; C, control.</p></fn>
</table-wrap-foot>
</table-wrap>
</floats-group>
</article>
